Fenfluramine hydrochloride bulk supplier for pharma manufacturers

Fenfluramine Hydrochloride 2.2 mg/mL, 5 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Oral Solution

Available Strengths: 2.2 mg/mL, 5 mg/mL

Reference Brands: Fintepla (USA, EU)

Category: Neurology

Fenfluramine hydrochloride is an antiepileptic medication used for the treatment of seizures associated with Dravet syndrome and Lennox–Gastaut syndrome in patients aged two years and older. It works by modulating serotonergic activity in the brain, helping reduce the frequency and severity of seizures. Fintepla is available as an oral solution in 2.2 mg/mL and 5 mg/mL strengths, with dosing customized to patient needs under strict monitoring programs.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Fenfluramine Hydrochloride — third party manufacturing & bulk supply

Fenfluramine Hydrochloride 2.2 mg/mL, 5 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Fenfluramine Hydrochloride is supplied as Oral Solution — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Fenfluramine Hydrochloride listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Fenfluramine Hydrochloride →

Back to Listing

Frequently Asked Questions

Fenfluramine hydrochloride is used to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients two years of age and older. It helps reduce the frequency and severity of seizures when used in combination with other antiepileptic medications. Previously, fenfluramine was used as an appetite suppressant, but its use for weight loss was discontinued due to cardiac side effects.

Fenfluramine hydrochloride is made from the active ingredient fenfluramine hydrochloride, a serotonin-releasing agent that also modulates sigma-1 receptors in the brain, helping to stabilize neuronal activity and reduce seizure episodes. Its chemical name is (±)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine hydrochloride. Inactive ingredients may vary depending on the formulation and manufacturer.

The trade name of fenfluramine hydrochloride is Fintepla.

Fenfluramine hydrochloride (Fintepla) is manufactured and marketed by UCB Pharma (formerly by Zogenix Inc., which was acquired by UCB).

The generic name of the drug is fenfluramine hydrochloride.

The brand name of fenfluramine hydrochloride is Fintepla.

Fenfluramine hydrochloride is manufactured in Europe and the United States by UCB Pharma and its licensed facilities. It is also distributed in other regions under regulatory approval for epilepsy treatment.